Olanzapine for chemotherapy-induced nausea: Lessons learned from child and adolescent psychiatry

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

(2017) Paul J. Hesketh et al.   JOURNAL OF CLINICAL ONCOLOGY

Olanzapine for prevention of chemotherapy-induced nausea and vomiting in children and adolescents: a multi-center, feasibility study

(2017) J. Flank et al.   SUPPORTIVE CARE IN CANCER

Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: an observational study in real-life settings

(2015) Marco Pozzi et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Psychosocial Interventions and Therapeutic Support as a Standard of Care in Pediatric Oncology

(2015) Amii C. Steele et al.   PEDIATRIC BLOOD & CANCER

Antipsychotic Medication Prescribing in Children Enrolled in Medicaid

(2015) D. C. Rettew et al.   PEDIATRICS

Olanzapine for treatment and prevention of acute chemotherapy-induced vomiting in children: A retrospective, multi-center review

(2014) Jacqueline Flank et al.   PEDIATRIC BLOOD & CANCER

The Diagnosis and Management of Delirium in Infancy

(2013) Susan Beckwitt Turkel et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Randomized, Double-Blind, Placebo-Controlled Study

(2013) Naomi Mizukami et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

(2013) Stefan Leucht et al.   LANCET

Case Reports of Postmarketing Adverse Event Experiences With Olanzapine Intramuscular Treatment in Patients With Agitation

(2010) Stephen R. Marder et al.   JOURNAL OF CLINICAL PSYCHIATRY

Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis

(2010) Christine Rummel-Kluge et al.   SCHIZOPHRENIA RESEARCH

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION